Table 1 Demographic characteristics and history of the disease-FAS population
Group | CIDP | anti-MAG | CMT1 | All |
|---|---|---|---|---|
Participants (n) | 5 | 5 | 5 | 15 |
Men (n) | 2 (40%) | 3 (60%) | 2 (40%) | 7 (47%) |
Women (n) | 3 (60%) | 2 (40%) | 3 (60%) | 8 (53%) |
Age (years) | 66 ± 15; 63 (61;79) | 69 ± 8; 65 (63;72) | 49 ± 11; 52 (49;55) | 61 ± 14; 62 (52;72) |
Time since first appearance of symptoms (years) | 18 ± 9; 14 (13;15) | 11 ± 11; 5 (3;17) | 11 ± 16; 5 (3;6) | 13 ± 12; 12 (3;17) |
Patients with progression (n) | 2 | 2 | 4 | 8 |
Time since progression (years) | 2.7 ± 1.5; 1.2 (1.0;1.3) | 1.9 ± 1.4; 1.9 (0.7;3.0) | 1.6 ± 1.4; 1.4 (0.6;2.5) | 1.7 ± 1.3; 1.3 (1.0;2.4) |